We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
Request received
Request received for information on the prevalence of insulin use, oral hypoglycaemic agent use, and VRIII (Variable Rate Intravenous Insulin Infusion) use in hospital in the UK at the time of the last National Diabetes Inpatient Audit (NaDIA).
Our response
Counts and percentages provided using data from the most recent National Diabetes Inpatient Audit (NaDIA) collection (September 2019, England only). Data for the whole of the UK (as requested) is not available.
Last edited: 23 November 2021 10:36 am